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Abstract
Background

In present study, we aimed to identify and evaluate the trends of the 100 most-cited research
articles on Covid-19 using bibliometric techniques.
Methods

Scopus online database hosted by Elsevier was used to extract relevant articles for this study. We
have identified the top 100 research papers on Covid-19 published across the globe based on
their citations data. Further analysis was made to find the countries of origin, journal wise
distribution, author cluster network, keyword analysis and inter-citation map to understand and
to establish the links among them.
Results

The T100 most cited articles were published between January-August, 2020 and their citations
ranged from 304 to 5295. The T100 articles were contributed by 24 countries, with more than
half is originated from China (n=63). Scientific publications originated from china received
highest citations (55,688) followed by USA (13,996) and Hong Kong (9,501). Although ‘New
England Journal of Medicine’ published the most papers (n=15) with the highest impact factor
value of (74.699) but studies published in ‘The Lancet’ has received highest citations
(n=18,431). The top five journals hold 44% of these influential studies. The Tongji medical
college, Huazhong University of science & technology, Wuhan, China is the top institution with
the most T100 articles in the field of Covid-19.

Conclusions

We analyzed the 100 most-cited articles in the field of Covid-19. China and USA are the
dominant countries in terms of the number of T100 articles, scientists and institutions. Scientific
publications originated from China also had the highest mean number of citations. The leading
institutions with the most productive articles were Tongji medical college, Jin yin-tan hospital,
Tsinghua university school of medicine (China) and University of North Carolina (US). The
study authored by Huang C on “Clinical features of patients infected with 2019 novel
coronavirus in Wuhan, China” has received maximum citations (5295).
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Introduction
Citations are the key indicators to measure the quality, authorship and influence of an
individual paper (Aksnes et al., 2019). Citation analysis measures the scientific performances of
literature at a relatively low financial cost (Garfield, 1979). Citations indicators are now widely
accepted and broadly applied to evaluate most-cited articles in different research domain.
Garfield publication entitled "Highly Cited Works in Mathematics" in 1973 considered as classic
paper which has given a depth insight to evaluate the highly cited papers. Citations values of a
scholarly communication are being used by researchers to position their research work
(Mansourizadeh & Ahmad, 2011). Citation-based approaches can reveal the dynamics of
scientific activities and conveys foresight into emerging trends (Chen & Song, 2019). The spread
of COVID-19 virus has created unprecedented chaos and posed one of the greatest threats before
the survival of the human race. The global scientific communities have responded to the crises
and coordinated effort is made to containing the spread of this epidemic & provides optimal care
to those affected by the disease (WHO, 2020). Research published on covid-19 in many
scientific journals in very short periods has increased tremendously. As per Scopus database,
there were 43,723 research documents published on coronavirus disease in just eight months into
the outbreak of the epidemic (during 01 January to 31 August 2020). However, we found that

there is a lack of comprehensive studies that provide an overall evaluation of the most-cited
papers on Covid-19. The purpose of the present study was to identify the 100 most-cited articles
on Covid-19 and to analyze their characteristics and inter-citation network.

Literature Reviewed
Coronavirus research publications trends are scattered and lie with many domains
including medical science, management, tourism, psychology, sociology and many more. These
studies mainly dealt with a wide variety of concerns like Covid-19 impact and effect on
community health and its relations with various diseases like diabetes, hypertension (Parohan et
al., 2020). Others domain studies are mainly concerned with COVID-19 impact on the industry,
tourism, socio-economic conditions and its relationship with lockdown, closed border
(Owojaiye; Lau et al.; Nikola et al., 2020). Research progress on Coronavirus and COVID-19
significantly focused on virology, epidemiology, and infectious diseases among others. However,
there seems to be gap in research areas related to public health, its governance, technology, and
communication (Zhang & Shaw, 2020). The emergence of COVID-19 has had a significant
impact in other fields, particularly the social science, technology, physical sciences and arts and
sciences, not just among clinical professionals(medical science) (Ruiz-Real et al., 2020).
Bibliometric studies on Coronavirus and Covid-19 mainly focused on citation pattern co-word or
cluster studies or Visualization in general context (Nicola et al.; Shamsi et al.; Fonkou et al.,
2020). However, there are only a few bibliometric studies conducted so far at the global level in
the context of both Coronavirus and Covid-19. The year 2020 is the witness of rapid scientific
publications on Covid-19 (Sahoo & Pandey, 2020). Researches conducted on top-cited papers on
Coronavirus are rare mainly published during 1973 to 2016 and appeared with the most
prominent source like 'Journal of Virology' and from the USA. The University of Hong Kong
became the most productive institute which published the most number of highly cited articles
(Ram & Nisha, 2020). Study has co-related the evolving research pattern of both Coronavirus

and Covid-19 and concluded that USA dominates in the research output, while most of the
influential institutions are from China (Sahoo & Pandey, 2020). Top fifty cited papers on Covid19 appeared in most reputed journals. The main focus of these papers was clinical/radiological
aspect of Covid-19 rather than treatments/vaccines (El Hawary, 2020).
Therefore, our study aimed at filling this knowledge gap by examining the global
research trends on Covid-19 pandemic based on a bibliometric analysis of most-cited 100 articles
in the year 2020. The primary objectives of our study are i) to identify the top 100 most-cited
articles on COVID-19 ii) to identify the sources that published the 100 most-cited papers iii) to
visualize the network of prominent authors based on their citations values iv) to analyze the
characteristics and inter-citation network of these influential studies.

Materials & Methods
SCOPUS online database hosted by Elsevier is used for this study. A well defined
systematic approach was adopted to retrieve the top cited publications. The following structured
search query was formulated and total of 43,723 published research documents were identified
on Covid-19 during 01 January to 31 August 2020. This search yielded 43,723 results, were then
sorted in descending order with respect to the citations count.
Search Query: ((TITLE-ABS-KEY(Covid-19) OR (Coronavirus) OR (Coronavirus disease
2019) OR (SARS-COV-2) OR (2019-nCov)) AND PUBYEAR > 2019 AND ( EXCLUDE (
DOCTYPE,"er" ) )

The identified records were further refined and datasets were fixed based on their
relevancy. Duplicate and irrelevant records & documents type such as ‘erratum’ has excluded
from the sample data. The final dataset of T100 most-cited articles was assessed and analyzed
using VOSviewer tool (Van Eck & Waltman, 2010). Citations data for this study was obtained
till 31 August 2020. The journals impact factor values were cross referenced with the 2020

edition of Journal Citation Reports (JCR). Visualization maps were created for understanding the
characters and influence of these studies.

Results
The most influential manuscripts (T100) were identified out of 43,514 records retrieved
from SCOPUS database. Table 1 shows the list of these most cited articles. The citations ranged
from 304 for Xiao et al. (“Evidence for Gastrointestinal Infection of SARS-CoV-2”) to 5,295 for
Huang et al. (“Clinical features of patients infected with 2019 novel coronavirus in Wuhan,
China”). In total 75,747 number of citation received by these top 100 studies.
Table 1. The top 100 most-cited papers on Covid-19
Rank

First Author

Title

Source title

Citation
Count

1

Huang C.

Clinical features of patients infected with 2019 novel
coronavirus in Wuhan, China

The Lancet

5295

2

Guan W.

Clinical characteristics of coronavirus disease 2019 in China

New England Journal of Medicine

3407

3

Wang D.

Clinical Characteristics of 138 Hospitalized Patients with 2019
Novel Coronavirus-Infected Pneumonia in Wuhan, China

JAMA - Journal of the American
Medical Association

3162

4

Zhu N.

New England Journal of Medicine

2889

5

Chen N.

The Lancet

2712

6

Zhou F.

A novel coronavirus from patients with pneumonia in China,
2019
Epidemiological and clinical characteristics of 99 cases of 2019
novel coronavirus pneumonia in Wuhan, China: a descriptive
study
Clinical course and risk factors for mortality of adult inpatients
with COVID-19 in Wuhan, China: a retrospective cohort study

The Lancet

2623

7

Wu Z.

JAMA - Journal of the American
Medical Association

2051

8

Zhou P.

Characteristics of and Important Lessons from the Coronavirus
Disease 2019 (COVID-19) Outbreak in China: Summary of a
Report of 72314 Cases from the Chinese Center for Disease
Control and Prevention
A pneumonia outbreak associated with a new coronavirus of
probable bat origin

Nature

2051

9

Li Q.

Early transmission dynamics in Wuhan, China, of novel
coronavirus-infected pneumonia

New England Journal of Medicine

2020

10

Lu R.

Genomic characterisation and epidemiology of 2019 novel
coronavirus: implications for virus origins and receptor binding

The Lancet

1465

11

Chan J.F.-W.

A familial cluster of pneumonia associated with the 2019 novel
coronavirus indicating person-to-person transmission: a study
of a family cluster

The Lancet

1436

12

Hoffmann M.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is
Blocked by a Clinically Proven Protease Inhibitor

Cell

1333

13

Yang X.

Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: a single-centered,
retrospective, observational study

The Lancet Respiratory Medicine

1195

14

Xu Z.

Pathological findings of COVID-19 associated with acute
respiratory distress syndrome

The Lancet Respiratory Medicine

1169

15

Van
Doremalen N.

Aerosol and surface stability of SARS-CoV-2 as compared with
SARS-CoV-1

New England Journal of Medicine

1103

16

Holshue M.L.

First case of 2019 novel coronavirus in the United States

New England Journal of Medicine

1087

17

Wang M.

Remdesivir and chloroquine effectively inhibit the recently
emerged novel coronavirus (2019-nCoV) in vitro

Cell Research

1063

18

Mehta P.

COVID-19: consider cytokine storm syndromes and
immunosuppression

The Lancet

1023

19

Gautret P.

International Journal of
Antimicrobial Agents

927

20

Wu C.

Hydroxychloroquine and azithromycin as a treatment of
COVID-19: results of an open-label non-randomized clinical
trial
Risk Factors Associated with Acute Respiratory Distress
Syndrome and Death in Patients with Coronavirus Disease
2019 Pneumonia in Wuhan, China

JAMA Internal Medicine

882

21

Wu F.

A new coronavirus associated with human respiratory disease
in China

Nature

872

22

Cao B.

New England Journal of Medicine

828

23

Liang W.

A trial of lopinavir-ritonavir in adults hospitalized with severe
covid-19
Cancer patients in SARS-CoV-2 infection: a nationwide analysis
in China

The Lancet Oncology

765

24

Zou L.

SARS-CoV-2 viral load in upper respiratory specimens of
infected patients

New England Journal of Medicine

757

25

Rothe C.

Transmission of 2019-NCOV infection from an asymptomatic
contact in Germany

New England Journal of Medicine

739

26

Wang C.

A novel coronavirus outbreak of global health concern

The Lancet

732

27

Ai T.

Correlation of Chest CT and RT-PCR Testing for Coronavirus
Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Radiology

692

28

Chen H.

Clinical characteristics and intrauterine vertical transmission
potential of COVID-19 infection in nine pregnant women: a
retrospective review of medical records

The Lancet

676

29

Wrapp D.

Cryo-EM structure of the 2019-nCoV spike in the prefusion
conformation

Science

671

30

Bai Y.

Presumed Asymptomatic Carrier Transmission of COVID-19

JAMA - Journal of the American
Medical Association

638

31

Wang W.

Detection of SARS-CoV-2 in Different Types of Clinical
Specimens

JAMA - Journal of the American
Medical Association

636

32

Corman V.M.

Eurosurveillance

627

33

Tang N.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time
RT-PCR
Abnormal coagulation parameters are associated with poor
prognosis in patients with novel coronavirus pneumonia

Journal of Thrombosis and
Haemostasis

626

34

Brooks S.K.

The psychological impact of quarantine and how to reduce it:
rapid review of the evidence

The Lancet

620

35

Mao L.

Neurologic Manifestations of Hospitalized Patients with
Coronavirus Disease 2019 in Wuhan, China

JAMA Neurology

582

36

Gorbalenya
A.E.

The species Severe acute respiratory syndrome-related
coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Nature Microbiology

578

37

Wan Y.

Journal of Virology

575

38

Wu J.T.

Receptor recognition by the novel coronavirus from Wuhan:
An analysis based on decade-long structural studies of SARS
coronavirus
Nowcasting and forecasting the potential domestic and
international spread of the 2019-nCoV outbreak originating in
Wuhan, China: a modelling study

The Lancet

554

39

Gao J.

BioScience Trends

553

40

Ruan Q.

Breakthrough: Chloroquine phosphate has shown apparent
efficacy in treatment of COVID-19 associated pneumonia in
clinical studies
Clinical predictors of mortality due to COVID-19 based on an
analysis of data of 150 patients from Wuhan, China

Intensive Care Medicine

551

41

Walls A.C.

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike
Glycoprotein

Cell

547

42

Shi H.

Radiological findings from 81 patients with COVID-19
pneumonia in Wuhan, China: a descriptive study

The Lancet Infectious Diseases

544

43

Richardson S.

JAMA - Journal of the American
Medical Association

542

44

Lai C.-C.

Presenting Characteristics, Comorbidities, and Outcomes
among 5700 Patients Hospitalized with COVID-19 in the New
York City Area
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and coronavirus disease-2019 (COVID-19): The epidemic and
the challenges

International Journal of
Antimicrobial Agents

532

45

Yao X.

In Vitro Antiviral Activity and Projection of Optimized Dosing
Design of Hydroxychloroquine for the Treatment of Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clinical infectious diseases : an
official publication of the
Infectious Diseases Society of
America
The Lancet Infectious Diseases

496

46

Dong E.

47

Zhang J.-J.

An interactive web-based dashboard to track COVID-19 in real
time
Clinical characteristics of 140 patients infected with SARS-CoV2 in Wuhan, China

Allergy: European Journal of
Allergy and Clinical Immunology

488

48

Onder G.

Case-Fatality Rate and Characteristics of Patients Dying in
Relation to COVID-19 in Italy

JAMA - Journal of the American
Medical Association

487

49

Grasselli G.

Baseline Characteristics and Outcomes of 1591 Patients
Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy
Region, Italy
Are patients with hypertension and diabetes mellitus at
increased risk for COVID-19 infection?

JAMA - Journal of the American
Medical Association

473

50

Fang L.

The Lancet Respiratory Medicine

472

51

Wolfel R.

Virological assessment of hospitalized patients with COVID2019
Clinical evidence does not support corticosteroid treatment
for 2019-nCoV lung injury

Nature

471

52

Russell C.D.

The Lancet

463

53

Lauer S.A.

The incubation period of coronavirus disease 2019 (CoVID-19)
from publicly reported confirmed cases: Estimation and
application
COVID-19 and Italy: what next?

Annals of Internal Medicine

455

54

Remuzzi A.

The Lancet

440

55

Hui D.S.

The continuing 2019-nCoV epidemic threat of novel
coronaviruses to global health-The latest 2019 novel
coronavirus outbreak in Wuhan, China
The epidemiology and pathogenesis of coronavirus disease
(COVID-19) outbreak

International Journal of Infectious
Diseases

432

56

Rothan H.A.

Journal of Autoimmunity

429

57
58

Dong Y.

Epidemiology of COVID-19 among children in China

Pediatrics

422

Chen T.

Clinical characteristics of 113 deceased patients with
coronavirus disease 2019: Retrospective study

The BMJ

416

59

Wang C.

Immediate psychological responses and associated factors
during the initial stage of the 2019 coronavirus disease
(COVID-19) epidemic among the general population in China

International Journal of
Environmental Research and Public
Health

414

60

Kampf G.

Persistence of coronaviruses on inanimate surfaces and their
inactivation with biocidal agents

Journal of Hospital Infection

411

61

Shi S.

Association of Cardiac Injury with Mortality in Hospitalized
Patients with COVID-19 in Wuhan, China

JAMA Cardiology

409

62

Qin C.

Dysregulation of Immune Response in Patients With
Coronavirus 2019 (COVID-19) in Wuhan, China

405

63

Zheng Y.-Y.

COVID-19 and the cardiovascular system

Clinical infectious diseases : an
official publication of the
Infectious Diseases Society of
America
Nature Reviews Cardiology

64

Guo Y.-R.

The origin, transmission and clinical therapies on coronavirus
disease 2019 (COVID-19) outbreak- A n update on the status

Military Medical Research

397

65

Chung M.

CT imaging features of 2019 novel coronavirus (2019-NCoV)

Radiology

396

66

Andersen K.G.

The proximal origin of SARS-CoV-2

Nature Medicine

393

67

Varga Z.

Endothelial cell infection and endotheliitis in COVID-19

The Lancet

392

68

Guo T.

Cardiovascular Implications of Fatal Outcomes of Patients with
Coronavirus Disease 2019 (COVID-19)

JAMA Cardiology

390

69

Grein J.

New England Journal of Medicine

379

70

Tang N.

Journal of Thrombosis and
Haemostasis

379

71

Yan R.

Compassionate use of remdesivir for patients with severe
Covid-19
Anticoagulant treatment is associated with decreased
mortality in severe coronavirus disease 2019 patients with
coagulopathy
Structural basis for the recognition of SARS-CoV-2 by fulllength human ACE2

Science

375

72

Shen C.

Treatment of 5 Critically Ill Patients with COVID-19 with
Convalescent Plasma

JAMA - Journal of the American
Medical Association

373

73

Chen G.

Clinical and immunological features of severe and moderate
coronavirus disease 2019

Journal of Clinical Investigation

369

490

403

74

Chan J.F.

Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical
pneumonia after visiting Wuhan

Emerging Microbes and Infections

366

75

Vaduganathan
M.

Renin-angiotensin-aldosterone system inhibitors in patients
with covid-19

New England Journal of Medicine

362

76

Yang J.

Prevalence of comorbidities and its effects in coronavirus
disease 2019 patients: A systematic review and meta-analysis

International Journal of Infectious
Diseases

356

77

Lu X.

SARS-CoV-2 infection in children

New England Journal of Medicine

356

78

Xu X.-W.

Clinical findings in a group of patients infected with the 2019
novel coronavirus (SARS-Cov-2) outside of Wuhan, China:
Retrospective case series

The BMJ

355

79

Klok F.A.

Incidence of thrombotic complications in critically ill ICU
patients with COVID-19

Thrombosis Research

352

80

Chen Y.

Emerging coronaviruses: Genome structure, replication, and
pathogenesis

Journal of Medical Virology

349

81

Lu H.

Outbreak of pneumonia of unknown etiology in Wuhan, China:
The mystery and the miracle

Journal of Medical Virology

346

82

Lai J.

Factors Associated With Mental Health Outcomes Among
Health Care Workers Exposed to Coronavirus Disease 2019

JAMA network open

346

83

Fang Y.

Sensitivity of chest CT for COVID-19: Comparison to RT-PCR

Radiology

344

84

Li R.

Substantial undocumented infection facilitates the rapid
dissemination of novel coronavirus (SARS-CoV-2)

Science

344

85

Sohrabi C.

World Health Organization declares global emergency: A
review of the 2019 novel coronavirus (COVID-19)

International Journal of Surgery

343

86

Liu Y.

The reproductive number of COVID-19 is higher compared to
SARS coronavirus

Journal of Travel Medicine

343

87

Li Y.-C.

The neuroinvasive potential of SARS-CoV2 may play a role in
the respiratory failure of COVID-19 patients

Journal of Medical Virology

341

88

Emanuel E.J.

New England Journal of Medicine

341

89

Xu X.

Science China Life Sciences

341

90

Jin Y.-H.

Military Medical Research

335

91

Young B.E.

Fair allocation of scarce medical resources in the time of covid19
Evolution of the novel coronavirus from the ongoing Wuhan
outbreak and modeling of its spike protein for risk of human
transmission
A rapid advice guideline for the diagnosis and treatment of
2019 novel coronavirus (2019-nCoV) infected pneumonia
(standard version)
Epidemiologic Features and Clinical Course of Patients Infected
with SARS-CoV-2 in Singapore

JAMA - Journal of the American
Medical Association

328

92

Liu J.

Hydroxychloroquine, a less toxic derivative of chloroquine, is
effective in inhibiting SARS-CoV-2 infection in vitro

Cell Discovery

326

93

Bhatraju P.K.

New England Journal of Medicine

326

94

To K.K.-W.

COVID-19 in critically ill patients in the Seattle region-Case
series
Temporal profiles of viral load in posterior oropharyngeal
saliva samples and serum antibody responses during infection
by SARS-CoV-2: an observational cohort study

The Lancet Infectious Diseases

325

95

Sheahan T.P.

Nature Communications

321

96

Zhang Y.

New England Journal of Medicine

315

97

Zhang W.

Comparative therapeutic efficacy of remdesivir and
combination lopinavir, ritonavir, and interferon beta against
MERS-CoV
Coagulopathy and antiphospholipid antibodies in patients with
covid-19
Molecular and serological investigation of 2019-nCoV infected
patients: implication of multiple shedding routes

Emerging Microbes and Infections

314

98

Hollander J.E.

Virtually perfect? Telemedicine for covid-19

New England Journal of Medicine

313

99

Ong S.W.X.

JAMA - Journal of the American
Medical Association

306

100

Xiao F.

Air, Surface Environmental, and Personal Protective
Equipment Contamination by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) from a Symptomatic
Patient
Evidence for Gastrointestinal Infection of SARS-CoV-2

Gastroenterology

304

The inter-citation network of highly cited T100 articles on Covid-19 is depicted in Figure 1.

Figure 1. Represents the inter-citation networks of most cited 100 articles on covid-19

The analysis of the literature on Covid-19 shows that the China ranked top with the
greatest number of publications (n=63) followed by United States of America (n=27) and United
Kingdom (n=13) publications. Results indicate that the T100 cited articles were altogether
contributed by 26 countries. Scientific publications originated from china received highest
citations (55,688) followed by USA (13,996) and Hong Kong (9,501). Other prominent countries
which are significantly contributed in these research studies are Hong Kong (n=10), Germany
(n=9, citation- 5313), Netherlands (n=5, citation- 2628), Italy (n=5, citation- 2211), France(n=4,
citation- 2480), Switzerland(n=4, citation- 1807) and Singapore(n=4, citation- 1445) .

The 100 most influential papers were scattered across 44 journals with the number of
manuscripts per journal ranging from 1 to 15. Only 18 journals have published two or more of
those articles whereas remaining journals are hold single publication. Journals published with
four or more articles along with impact factor values shown in Table 2. Although ‘The New
England Journal of Medicine’ published the most papers (n = 15), with highest impact factor of
(74.699) but studies published in ‘The Lancet’ has received highest citations (n=18,431). The top

five journals hold 44% of these influential studies. Most of these influential studies are published
in well qualified journal with significant higher value of impact factor.
Table 2. Journals with four or more articles in the top 100.
Journal Title

NP

TC

ACP

The New England Journal of Medicine

15

15222

1014.80

JIF as of
2019
74.699

The Lancet

13

18431

1417.77

60.392

JAMA - Journal of the American Medical Association

10

8996

899.60

45.54

Nature

3

3394

1131.33

42.778

The Lancet Respiratory Medicine

3

2836

945.33

25.094

Radiology

3

1432

477.33

7.931

Science

3

1390

463.33

41.845

The Lancet Infectious Diseases

3

1359

453.00

24.446

Journal of Medical Virology

3

1036

345.33

2.021

Cell

2

1880

940.00

38.637

International Journal of Antimicrobial Agents

2

1459

729.50

4.621

Journal of thrombosis and haemostasis

2

1005

502.50

4.157

Clinical infectious diseases

2

901

450.50

8.313

JAMA Cardiology

2

799

399.50

12.794

International Journal of Infectious Diseases

2

788

394.00

3.202

The BMJ

2

771

385.50

30.223

Military Medical Research

2

732

366.00

2.325

Emerging Microbes and Infection

2

680

340.00

5.776

The result revealed that the most publishing author Zhang I (n=6) has link strength of 285
received 6598 citations where as Chen H has published 6 papers but his link strength of 405 is
highest in the network. The top 5 authors with the maximum contribution and largest total link
strength were Zhang I (TP=6, TC=6598, TLS=285), Wang W(TP=6, TC=6118, TLS=206),
Wang Y(TP=6, TC=6045, TLS=139), Chen H (TP=6, TC=5845, TLS=405) and Drosten
C(TP=6, TC=4180, TLS=298). Our purpose is not to rank authors; rather, we attempt to identify
the most active researchers in order to understand their contribution towards the growth of the
field. The cluster of author network map is displayed in Figure 2.
Co-occurrence of keywords analysis using VOSviewer tool is conducted and the results
indicated the key concepts that have been explored by researchers in these 100 most-cited
articles (Sahoo & Pandey, 2020). The research focus of these top 100 papers were found to be

mainly clinical characteristics of the epidemic, early transmission, infection, diagnosis,
experimental treatments and care. Results of clusterwise keywords analysis is shown in Figure 3.

Discussions
In this study, we identify, rank and characterize the top 100 most cited research articles
on Covid-19. The quantitative information about active authors, prominent institutions and core
journals that published these influential studies was also provided. Usually an article received
more citations with increasing age, and longer citable period. However, in our analysis, reveals
that the number of research articles increased tremendously in this field in the last eight months.
The domain has received the attention of the global scientific communities due to the magnitude
of impact on public health and the rapid spread of the disease. COVID-19 has not only impacted
hugely on global health, businesses but also disrupted the world economics (Haleem et al.,
2020).
Citation map of top 100 studies on covid-19 is depicted in Figure 1. The citations count
of an article partly depends on the early publication of the article, as citations accumulate over
the years. However, we observed these papers are received huge citations in a very short time.
This unusual growth may be attributed due to the novelty of these studies and the global impact
of the disease. Publishing in open access platform has definitely generated wider visibility of
these works and the knowledge being shared among the global research communities actively
engaged in covid-19 pandemic.
Country wise distribution analysis indicated that the China has contributed maximum
research publications (n=63) followed by United States of America (n=27) and United Kingdom
(n=13). Scientific publications originated from china received highest citations (55688) followed
by USA (13996) and Hong Kong (9501). Although scientific publications originated from the
China had received highest citations but research studies from Hong Kong received highest

average citation per paper (950.10). Overall 26 countries together contributed to the top 100 most
cited articles.
Of the total T100 articles, the leading institutions with the most productive articles were
(Tongji medical college, Huazhong university of science and technology, Wuhan, China), (Jin
yin-tan hospital, Wuhan, China), (Tsinghua university school of medicine, Beijing, China) and
University of North Carolina, United States.

This finding illustrates the inverse correlation between average citations per year since
publication and article age. It was a surprise to see such a trend and phenomenal growth of
citations for younger publications.
The 100 most influential papers were scattered across 44 journals with the number of
manuscripts per journal ranging from 1 to 15. Only 18 journals published 2 or more papers
whereas remaining 26 sources hold single publication each. Although ‘The New England Journal
of Medicine’ published the most papers (n = 15), with highest impact factor of (74.699) but
studies published in ‘The Lancet’ has received highest citations (n=18,431). The top five journals
hold 44% of these influential studies. Most of these influential studies are published in well
qualified journal with significant higher value of impact factor. The range of impact factor values
for these sources varies from 2.021 to 74.699.
Authorship analysis was performed to have better understanding of research collaboration
among the scientific community. Out of 732 authors only 127 authors having minimum 2
publications are considered for creating cluster network and displayed in Figure 2. Each node in
the graph presents an author, the size of the node depicts number articles the author has
published, and the connection indicates cooperative relationship among these authors. From the
figure, it can be seen that the most prolific authors are usually located in the core of the network
and the distance between them is shortest. Each cluster of authors is distinguished by different

colors code and the line shows the links strength between them. The result revealed that the most
publishing author Zhang I (n=6) has link strength of 285 received 6598 citations where as Chen
H has published 6 papers but his link strength of 405 is highest in the network. The top 5 authors
with the maximum contribution and largest total link strength were Zhang I (TP=6, TC=6598,
TLS=285), Wang W(TP=6, TC=6118, TLS=206), Wang Y(TP=6, TC=6045, TLS=139), Chen H
(TP=6, TC=5845, TLS=405) and Drosten C(TP=6, TC=4180, TLS=298).

Figure 2. Represent network map of prominent authors based on their citations values and link strength

Co-occurrence of keywords analysis was conducted to find out the key concepts that have
been explored by the researchers in these 100 most-cited articles. This was done by analyzing the
data using VOSviewer application tool, and the results are shown in Figure 3. A minimum
occurrence of 5 or more is fixed and only 185 keywords are qualified for generating the network
map. These key terms are grouped in to 4 clusters distinguished by different color. It has been
found that, the most repeated keyword (frequency = 84) in cluster-3 is ‘coronavirus infection’
with link strength 2078. This particular keyword has strong associations with ‘human’
(frequency = 81) in cluster-2 and ‘China’ (frequency = 63) of cluster-3 and also with ‘virus
pneunomia’ (frequency = 62) of cluster-4. As seen from Figure 3 the second, third and four

clusters are positioned close to each other in the network while at the same time first cluster is
little far away. This reveals the close and strong association between the keywords in these 2, 3
& 4 clusters compared with the cluster-1 depicting the origin and nature of the epidemic &
humans are the most affected by Covid-19 disease. It is also observed that much of these works
are focus on the virus origin, infection prevention and control, pathological findings and clinical
aspects of disease & no much research attention was drawn towards potential drugs to control the
epidemic.

Figure 3. Represent the Keyword clusters map based on their influences & occurrences

Conclusions
In the current study, we summarized most of the influential studies on Covid-19 based on
top citations, and highlights research areas that require further investigation. Our analysis
provides an insight into the top-cited research articles on Covid-19(SARS-COV-2) and
highlights the impact of the studies, discoveries and global research trends. China has
contributed maximum influential research publications followed by United States of America
and United Kingdom. Scientific publications originated from the China also had the highest
mean number of citations. The leading institutions with the most productive articles were Tongji

medical college, Jin yin-tan hospital, Tsinghua university school of medicine (China) and
University of North Carolina (USA). The study authored by Huang C on “Clinical features of
patients infected with 2019 novel coronavirus in Wuhan, China” has received maximum citations
of 5,295. The study presented an outlook to T100 top research papers which is limited to the
citation data extracted from Scopus database. Future studies may be conducted by considering
other citation databases like PubMed, WoS and Dimesion Data. An altemtrics study may be
carried out to see the correlation between citation and altemtrics score. Study revealed several
interesting findings and results of the study may be taken as pointer for the further bibliometric
study on SARS-COV-2.
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